| Literature DB >> 35018324 |
Chinedu A Akwuobu1, Emmanuel O Ngbede1, Levi M Mamfe1, Ekene V Ezenduka2, Kennedy F Chah3.
Abstract
This cross-sectional study was carried out to determine the common Gram-negative bacteria (GNB) contaminating veterinary clinic environments, and to evaluate the susceptibility of the isolates to commonly used antibiotics and biocides. A total of 62 swab samples were collected from different frequently touched surfaces in the 4 veterinary clinics visited. The samples were processed for isolation and identification of GNB using standard microbiological procedures. The susceptibility of the isolates to disinfectants and antibiotics was determined using agar dilution and disc diffusion techniques, respectively. A total of 114 GNB were isolated from the 4 clinics with isolation rates of 21.9, 22.8, 23.7 and 31.6% in clinics A, B, C and D, respectively. The surfaces of treatment tables were more contaminated (16.7 %) than receptionist/clinician desks (15.8%), weighing balances (10.5 %), door handles (7.9 %), drip stands (7.9 %), handwashing basins (7.0 %) and client chairs (7.0%). The surface-contaminating isolates were distributed into 20 genera, with members of Enterobacteriaceae predominating (n=97). Fifty-nine per cent of the isolates were resistant to the disinfectant Septol, while 5.3 and 0.9% were resistant to Purit and Dettol disinfectants, respectively. Multiple drug resistance was observed among 99% of the isolates with approximately 100% resistance to beta-lactams. Phenotypic expression of extended-spectrum (3.5 %) and AmpC beta-lactamase (38.6 %) production was detected. These findings highlight the role of clinic environments in serving as reservoirs for potential pathogens and sources for the spread of multi-drug resistant GNB.Entities:
Keywords: infection; Gram-negative bacteria; biocides; pathogens; surfaces; veterinary clinics
Year: 2021 PMID: 35018324 PMCID: PMC8742594 DOI: 10.1099/acmi.0.000277
Source DB: PubMed Journal: Access Microbiol ISSN: 2516-8290
Isolation rate for potentially pathogenic bacteria from the veterinary clinic environment
|
Isolates |
Clinics (%)* |
Total (%)† | |||
|---|---|---|---|---|---|
|
A |
B |
C |
D | ||
|
|
20 (20.6) |
20 (20.6) |
27 (27.8) |
30 (30.9) |
97 (85.1) |
|
Non-enteric Gram-negative bacteria |
5 (29.4) |
6 (35.3) |
7 (41.2) |
6 (35.3) |
17 (14.9) |
|
Total |
25 (21.9) |
26 (22.8) |
27 (23.7) |
36 (31.6) |
114 |
*% of row total.
†% of row total.
Fig. 1.Summary of distribution of Gram-negative bacteria isolated from surfaces of veterinary clinics in Makurdi, Benue State. Weighing balance, WB; drip stand, DS; treatment room floor, TRF; handwashing basin, HB; animal waiting area floor, AWAF; waste bin handles, WBH; receptionist/clinician desks, RCD; door handles, DH; drug cabinet, DC; treatment tables, TT; clinic fridge door handles, CFDH; clinic switches, CS; client chairs, CC; kidney dish, KD; animal bath, AB.
Frequency of isolation of from the veterinary clinic environment
|
Isolates |
Frequency (%) |
|---|---|
|
|
11 (11.3) |
|
|
19 (19.6) |
|
|
5 (5.2) |
|
|
1 (1.0) |
|
|
4 (4.1) |
|
|
20 (20.6) |
|
|
1 (1.0) |
|
|
12 (12.4) |
|
|
1 (1.0) |
|
|
9 (9.3) |
|
|
2 (2.1) |
|
|
3 (3.1) |
|
|
1 (1.0) |
|
|
1 (1.0) |
|
|
1 (1.0) |
|
|
1 (1.0) |
|
Others |
5 (5.2) |
|
Total |
97 |
%=percentage of total number of isolates of Enterobacteriaceae
Frequency of isolation of non-enteric Gram-negative bacilli from the veterinary clinic environment
|
Isolates |
Frequency (%) |
|---|---|
|
|
5 (29.4) |
|
|
4 (23.5) |
|
|
1 (5.9) |
|
|
1 (5.9) |
|
|
1 (5.9) |
|
|
1 (5.9) |
|
|
1 (5.9) |
|
|
1 (5.9) |
|
|
1 (5.9) |
|
Others |
1 (5.9) |
|
Total |
17 |
%, percentage of total number of isolates of non-enteric Gram-negative bacilli.
Frequency of biocide susceptibility/resistance for bacterial isolates
|
Isolates |
No. susceptible to all biocides (%)* |
Resistant to |
Total (%)† | |
|---|---|---|---|---|
|
One biocide (%)* |
Two biocides (%)* | |||
|
|
36 (37.1) |
56 (57.7) |
5 (8.2) |
97 (85.1) |
|
Non-enteric Gram-negative bacilli |
10 (58.8) |
6 (35.3) |
1 (5.9) |
17 (14.9) |
|
Total |
46 (40.4) |
62 (54.4) |
6 (5.3) |
114 |
*% of row total.
†% of total bacterial isolates (114).
Frequency of biocide resistance for bacterial isolates
|
No. of isolates (%)* | |||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
1 (1.0) |
60 (61.9) |
5 (5.2) |
– |
– |
|
Non-enteric Gram-negative bacilli ( |
– |
7 (41.2) |
1 (5.9 |
– |
– |
|
Total ( |
1(0.9) |
67 (58.8) |
6 (5.3) |
– |
– |
*% of total isolates for each bacterial group.
Frequency of biocide MIC for Gram-negative bacteria
|
MIC (µl ml−1) |
No. of isolates (%)* | ||||
|---|---|---|---|---|---|
|
Dettol |
Septol |
Purit |
Tetmosol |
Z Germicide | |
|
50 |
– |
35 (30.7) |
7 (6.1) |
– |
– |
|
25 |
6 (5.3) |
2 (1.8) |
25 (21.9) |
1 (0.9) |
10 (8.8) |
|
12.5 |
15 (13.2) |
6 (5.3) |
29 (25.4) |
1 (0.9) |
97 (85.1) |
|
6.25 |
65 (57.0) |
4 (3.5) |
28 (24.6) |
45 (39.5) |
7 (6.1) |
|
3.13 |
24 (21.1) |
– |
13 (11.4) |
62 (54.4) |
– |
|
1.56 |
3 (2.6) |
– |
3 (2.6) |
4 (3.5) |
– |
|
0.78 |
– |
– |
3(2.6) |
1(0.9) |
– |
|
0.391 |
– |
– |
– |
– |
– |
|
0.195 |
– |
– |
– |
– |
– |
|
0.098 |
– |
– |
– |
– |
– |
|
Total |
113 (99.1) |
47 (41.2) |
108 (94.7) |
114 (100) |
114 (100) |
*Percentage of total isolates tested.
Frequency of biocide MBC for Gram-negative bacteria
|
MBC (µl ml−) |
No. of isolates (%)* | ||||
|---|---|---|---|---|---|
|
Dettol |
Septol |
Purit |
Tetmosol |
Z Germicide | |
|
50 |
3 (2.6) |
35 (30.7) |
24 (21.1) |
– |
1 (0.9) |
|
25 |
77 (67.5) |
3 (2.6) |
70 (61.4) |
17 (14.9) |
111 (97.4) |
|
12.5 |
11 (9.6) |
3 (2.6) |
10 (8.8) |
75 (65.8) |
– |
|
6.25 |
20 (17.5) |
– |
– |
19 (16.7) |
– |
|
3.13 |
– |
– |
1 (0.9) |
– |
– |
|
1.56 |
1 (0.9) |
– |
1 (0.9) |
1 (0.9) |
– |
|
0.78 |
– |
– |
– |
– |
– |
|
Total |
112 (98.2) |
41 (36.0) |
102 (89.5) |
112 (98.2) |
112 (98.2) |
*Percentage of total isolates tested.
Summary of antibiogram of
|
Antibiotics |
No. of isolates (%)* | |||
|---|---|---|---|---|
|
S |
I |
R |
Total | |
|
Penicillin |
0 |
1 (1) |
75 (99) |
76 |
|
Amoxicillin |
3 (4) |
0 |
82 (96) |
85 |
|
Imipenem |
17 (20) |
27 (33) |
40 (48) |
84 |
|
Cefoxitin |
26 (31) |
10 (12) |
47 (57) |
83 |
|
Cefpodoxime |
22 (28) |
18 (23) |
38 (49) |
78 |
|
Gentamicin |
11 (13) |
33 (40) |
39 (47) |
83 |
|
Streptomycin |
1 (1) |
2 (3) |
72 (96) |
75 |
|
Tetracycline |
21 (26) |
2 (2) |
62 (73) |
85 |
|
Chloramphenicol |
37 (43) |
15 (17) |
34 (40) |
86 |
|
Enrofloxacin |
34 (40) |
24 (28) |
28 (33) |
86 |
|
Sulphamethoxazole/trimethoprim |
30 (35) |
5 (6) |
51 (59) |
86 |
*% of row total.
Antibiogram of non-enteric Gram-negative bacilli
|
No. of isolates (%)* | ||||
|---|---|---|---|---|
|
|
|
|
|
|
|
Penicillin |
0 |
0 |
8 (100) |
8 |
|
Amoxicillin |
0 |
0 |
11 (100) |
11 |
|
Imipenem |
10 (91) |
0 |
1 (9) |
11 |
|
Cefoxitin |
5 (63) |
2 (25) |
1 (13) |
8 |
|
Cefpodoxime |
2 (25) |
2 (25) |
4 (50) |
8 |
|
Gentamicin |
6 (55) |
2 (18) |
3 (27) |
11 |
|
Streptomycin |
0 |
1 (13) |
7 (88) |
8 |
|
Tetracycline |
5 (45) |
0 |
6 (55) |
11 |
|
Chloramphenicol |
1 (9) |
1 (9) |
9 (82) |
11 |
|
Enrofloxacin |
7 (64) |
2 (18) |
2 (18) |
11 |
|
Sulphamethoxazole/trimethoprim |
6 (55) |
0 |
5 (45) |
11 |
*% of row total.
Antibiotic resistance patterns of the Gram-negative bacilli
|
S/no. |
Pattern |
Frequency (%) |
|---|---|---|
|
1. |
|
1 |
|
2. |
S+C+SXT |
1 |
|
3. |
|
3 |
|
4. |
CN+AML+CPD |
1 |
|
5. |
|
1 |
|
6. |
|
2 |
|
7. |
|
3 |
|
8. |
|
1 |
|
9. |
|
1 |
|
10. |
|
1 |
|
11. |
IPM+P+S+AML+FOX |
1 |
|
12. |
IPM+P+S+CN+AML |
1 |
|
13. |
|
2 |
|
14. |
IPM+P+S+AML+TE |
3 |
|
15. |
|
1 |
|
16. |
ENR+P+S+AML+SXT |
1 |
|
17. |
|
3 |
|
18. |
|
3 |
|
19. |
ENR+P+S+AML+TE+SXT |
1 |
|
20. |
|
1 |
|
21. |
|
1 |
|
22. |
|
1 |
|
23. |
|
1 |
|
24. |
IPM+P+S+CN+AML+FOX |
1 |
|
25. |
IPM+P+S+AML+TE+SXT |
1 |
|
26. |
|
1 |
|
27. |
IPM+P+S+AML+TE+FOX |
5 |
|
28. |
|
2 |
|
29. |
IPM+P+S+C+AML+TE |
3 |
|
30. |
IPM+P+S+CN+AML+TE+SXT |
1 |
|
31. |
|
3 |
|
32. |
|
1 |
|
33. |
IPM+P+S+AML+TE+FOX+CPD |
2 |
|
34. |
IPM+P+S+AML+TE+SXT+FOX |
1 |
|
35. |
ENR+P+S+AML+TE+SXT+FOX |
2 |
|
36. |
|
2 |
|
37. |
ENR+P+S+C+CN+AML+SXT |
1 |
|
38. |
IPM+ENR+ |
1 |
|
39. |
IPM+ENR+ |
1 |
|
40. |
IPM+P+S+CN+AML+TE+SXT+FOX |
1 |
|
41. |
|
1 |
|
42. |
IPM+P+S+C+CN+AML+FOX+CPD |
1 |
|
43. |
ENR+P+S+C+CN+AML+TE+SXT |
3 |
|
44. |
|
2 |
|
45. |
|
2 |
|
46. |
ENR+P+S+CN+AML+TE+SXT+CPD |
1 |
|
47. |
IPM+P+S+C+CN+AML+TE+SXT+FOX |
1 |
|
48. |
ENR+P+S+CN+AML+TE+SXT+FOX+CPD |
1 |
|
49. |
ENR+P+S+C+CN+AML+TE+SXT+FOX |
1 |
|
50. |
|
2 |
|
51. |
IPM+ENR+ |
4 |
|
52. |
IPM+ENR+ |
6 |
|
53. |
IPM+P+S+C+CN+AML+TE+SXT+FOX+CPD |
2 |
|
54. |
IPM+ENR+ |
1 |
|
55. |
ENR+P+S+C+CN+AML+TE+SXT+FOX+CPD |
3 |
|
56. |
IPM+ENR+ |
2 |